MAPT and Alzheimer disease: However, in 3xTg‐AD mice, PAK1 KO or reduced PAK activity worsened synaptic and cognitive impairments and elevated phosphorylated tau (p‐tau) levels in aged animals, despite having no effect on Aβ pathology.20, 21